SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-13-001776
Filing Date
2013-01-10
Accepted
2013-01-10 17:17:12
Documents
3
Group Members
BAKER BROS. ADVISORS, LLCFBB ASSOCIATESFELIX J. BAKER

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v331756_sc13da.htm SC 13D/A 101439
2 EXHIBIT 10.1 v331756_ex10-1.htm EX-10.1 13553
3 EXHIBIT 99.1 v331756_ex99-1.htm EX-99.1 7652
  Complete submission text file 0001144204-13-001776.txt   124147
Mailing Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421
Business Address 128 SPRING STREET SUITE 520 LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Subject) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52299 | Film No.: 13523563
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE, 21ST FLOOR NEW YORK NY 10065
Business Address
BAKER JULIAN (Filed by) CIK: 0001087939 (see all company filings)

Type: SC 13D/A